Add to ORKGHospital-based descriptive study was done from January 2017 to December 2017. The study was carried out in 100 breast cancer patients, attending the Medical Oncology Department of Yangon General Hospital by using convenience non-probability sampling method. The positive expression rate of ER, PR receptors observed were 53% and 57 % respectively. Her2/neu positive expression was 34% and equivocal (8%). The mean age of breast cancer patients was 51.1 years with the youngest being 26 and the oldest,78
Background&Objective: The breast cancer is the most common malignancy in women. The normal and malig...
Background: Carcinoma breast is the commonest malignancy of females all over the world and second le...
Aim: HER-2/neu amplification occurs in 15-25% of breast carcinomas. This oncogene, also referred to ...
Objective: Study was designed to evaluate the expression status of HER2/neu receptor in breast cance...
BACKGROUND: Breast cancer is one of the commonest form of cancer leading to considerable mortality a...
Background: Breast cancer is the most common cancer in woman that originates from the uncontrolled g...
Objective: This research is designed to diagnose HER – 2 positivity among the cases of breast cancer...
Objective: To determine the frequency of human epidermal growth factor receptor 2 (HER-2/neu) posit...
Objective: The main purpose of this study was to evaluate the condition of the HER-2/Neu receptor in...
Background: Breast cancer is a major health problem for women throughout the world representing near...
Background: Breast cancer is one of the most common malignancies affecting the female population wor...
INTRODUCTION: The approach to the management of breast carcinoma has undergone enormous changes ove...
Objective: To find out the frequency of HER-2/Neu receptor status in invasive breast cancer patient...
Breast cancer is common worldwide and has high morbidity and mortality. Most of the patients in Indi...
Background: A significant development in the Breast malignancy, the expression of Hormone receptors ...
Background&Objective: The breast cancer is the most common malignancy in women. The normal and malig...
Background: Carcinoma breast is the commonest malignancy of females all over the world and second le...
Aim: HER-2/neu amplification occurs in 15-25% of breast carcinomas. This oncogene, also referred to ...
Objective: Study was designed to evaluate the expression status of HER2/neu receptor in breast cance...
BACKGROUND: Breast cancer is one of the commonest form of cancer leading to considerable mortality a...
Background: Breast cancer is the most common cancer in woman that originates from the uncontrolled g...
Objective: This research is designed to diagnose HER – 2 positivity among the cases of breast cancer...
Objective: To determine the frequency of human epidermal growth factor receptor 2 (HER-2/neu) posit...
Objective: The main purpose of this study was to evaluate the condition of the HER-2/Neu receptor in...
Background: Breast cancer is a major health problem for women throughout the world representing near...
Background: Breast cancer is one of the most common malignancies affecting the female population wor...
INTRODUCTION: The approach to the management of breast carcinoma has undergone enormous changes ove...
Objective: To find out the frequency of HER-2/Neu receptor status in invasive breast cancer patient...
Breast cancer is common worldwide and has high morbidity and mortality. Most of the patients in Indi...
Background: A significant development in the Breast malignancy, the expression of Hormone receptors ...
Background&Objective: The breast cancer is the most common malignancy in women. The normal and malig...
Background: Carcinoma breast is the commonest malignancy of females all over the world and second le...
Aim: HER-2/neu amplification occurs in 15-25% of breast carcinomas. This oncogene, also referred to ...